HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health ...

Ayble Health’s Series A round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...

Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst ...

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...

Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration ...

Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type ...